Colinz Laboratories Limited (BOM:531210)
India · Delayed Price · Currency is INR 80.00
-0.72 (-0.89%)
At close: Aug 18, 2026
Colinz Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 58.11 | 61.36 | 65.28 | 70.3 | 71.55 | 69.74 | |
Revenue Growth | -8.45% | -6.00% | -7.14% | -1.75% | 2.59% | 13.24% |
Cost of Revenue | 15.33 | 17.1 | 21.41 | 24.46 | 23.94 | 23.74 |
Gross Profit | 42.78 | 44.26 | 43.87 | 45.84 | 47.61 | 46.01 |
Selling, General & Admin | 26.74 | 26.96 | 30.27 | 31.34 | 32.2 | 30.34 |
Other Operating Expenses | 12.7 | 13.23 | 8.65 | 9.08 | 9.09 | 9.8 |
Operating Expenses | 41.01 | 41.75 | 40.23 | 41.72 | 42.57 | 42.16 |
Operating Income | 1.78 | 2.51 | 3.64 | 4.13 | 5.04 | 3.85 |
Interest Expense | -0.42 | -0.47 | -0.42 | -0.37 | -0.52 | -0.76 |
Interest & Investment Income | - | - | 2.88 | 2.74 | 1.7 | 1.67 |
Other Non Operating Income (Expenses) | 5.31 | 4.84 | 0.1 | 0.01 | 0.02 | 0.04 |
EBT Excluding Unusual Items | 6.66 | 6.89 | 6.19 | 6.5 | 6.24 | 4.8 |
Gain (Loss) on Sale of Assets | 27.63 | - | - | - | -0.24 | - |
Pretax Income | 34.3 | 6.89 | 6.19 | 6.5 | 6 | 4.8 |
Income Tax Expense | 6.33 | 1.75 | 1.23 | 1.64 | 1.42 | 1.41 |
Net Income | 27.97 | 5.15 | 4.97 | 4.87 | 4.57 | 3.39 |
Net Income to Common | 27.97 | 5.15 | 4.97 | 4.87 | 4.57 | 3.39 |
Net Income Growth | 484.31% | 3.60% | 2.03% | 6.41% | 34.81% | 63.44% |
Shares Outstanding (Basic) | 3 | 3 | 3 | 3 | 3 | 5 |
Shares Outstanding (Diluted) | 3 | 3 | 3 | 3 | 3 | 5 |
Shares Change | -0.07% | 0.05% | -0.04% | 0.34% | -45.19% | -0.61% |
EPS (Basic) | 11.11 | 2.04 | 1.97 | 1.93 | 1.82 | 0.74 |
EPS (Diluted) | 11.11 | 2.04 | 1.97 | 1.93 | 1.82 | 0.74 |
EPS Growth | 484.71% | 3.55% | 2.07% | 6.04% | 145.95% | 64.44% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 25.41 | -17.16 | 10.35 | 4.03 | 4.3 |
Free Cash Flow Per Share | - | 10.08 | -6.81 | 4.10 | 1.60 | 0.94 |
Gross Margin | 73.63% | 72.13% | 67.21% | 65.21% | 66.54% | 65.97% |
Operating Margin | 3.06% | 4.09% | 5.58% | 5.87% | 7.04% | 5.52% |
Profit Margin | 48.13% | 8.38% | 7.61% | 6.92% | 6.39% | 4.87% |
Free Cash Flow Margin | - | 41.41% | -26.28% | 14.72% | 5.63% | 6.16% |
EBITDA | 3.4 | 4.08 | 4.95 | 5.43 | 6.33 | 5.86 |
EBITDA Margin | 5.86% | 6.64% | 7.58% | 7.72% | 8.84% | 8.40% |
D&A For EBITDA | 1.63 | 1.56 | 1.31 | 1.3 | 1.29 | 2.01 |
EBIT | 1.78 | 2.51 | 3.64 | 4.13 | 5.04 | 3.85 |
EBIT Margin | 3.06% | 4.09% | 5.58% | 5.87% | 7.04% | 5.52% |
Effective Tax Rate | 18.46% | 25.34% | 19.83% | 25.16% | 23.74% | 29.36% |
Revenue as Reported | 63.42 | 66.21 | 68.26 | 73.05 | 73.27 | 71.45 |
Advertising Expenses | - | - | 0.18 | 0.11 | 0.16 | 0.11 |